Skip to main content
NCBI home page
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
. 1978 Sep 9;119(5):435–441.

Non-Hodgkin's lymphomas in Saskatchewan: a clinicopathologic study

Thomas Cherian, Leo F Skinnider, Joanne L Wright, Gabriel Komjathy
PMCID: PMC1818497  PMID: 356951

Abstract

In a retrospective clinical study of 208 previously untreated persons with non-Hodgkin's lymphomas the disorders were classified and staged according to the histopathologic criteria of Rappaport, Winter and Hicks and the Ann Arbor clinical staging classification.

Nodular types constituted 22% and diffuse types 78% of the lymphomas. The nodular lymphomas were slightly more common in females and were clustered in the age range 30 to 90 years. The diffuse lymphomas were slightly more common in males; the age distribution was bimodal, with one peak in the age range 10 to 19 years and the other in the age range 60 to 69 years, but when the age distribution of the general population in which the lymphomas occurred was taken into account, the incidence of these lymphomas was found to be significantly higher (P < 0.001) in persons more than 69 years of age than in those 40 to 69 years of age.

Survival correlated with histopathologic type: persons with nodular (follicular) lymphomas and diffuse lymphocytic well differentiated lymphomas had a significantly greater survival (P < 0.05) than those with other diffuse lymphomas. No significant difference in survival was noticed between persons with nodal and extranodal lymphomas.

While Rappaport and colleagues' criteria are still very useful, it is important to recognize the nodular lymphoma as a specific entity requiring generally different management from diffuse lymphomas. Appreciation of the different biologic behaviour of the various lymphomas is important to clinicians planning therapy.

Full text

PDF
435

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BERKSON J., GAGE R. P. Calculation of survival rates for cancer. Proc Staff Meet Mayo Clin. 1950 May 24;25(11):270–286. [PubMed] [Google Scholar]
  2. Carbone P. P., Kaplan H. S., Musshoff K., Smithers D. W., Tubiana M. Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res. 1971 Nov;31(11):1860–1861. [PubMed] [Google Scholar]
  3. Dorfman R. F. Letter: Classification of non-Hodgkin's lymphomas. Lancet. 1974 Jun 22;1(7869):1295–1296. doi: 10.1016/s0140-6736(74)90061-0. [DOI] [PubMed] [Google Scholar]
  4. Freeman C., Berg J. W., Cutler S. J. Occurrence and prognosis of extranodal lymphomas. Cancer. 1972 Jan;29(1):252–260. doi: 10.1002/1097-0142(197201)29:1<252::aid-cncr2820290138>3.0.co;2-#. [DOI] [PubMed] [Google Scholar]
  5. Gall E. A., Mallory T. B. Malignant Lymphoma: A Clinico-Pathologic Survey of 618 Cases. Am J Pathol. 1942 May;18(3):381–429. [PMC free article] [PubMed] [Google Scholar]
  6. HICKS E. B., RAPPAPORT H., WINTER W. J. Follicular lymphoma; a re-evaluation of its position in the scheme of malignant lymphoma, based on a survey of 253 cases. Cancer. 1956 Jul-Aug;9(4):792–821. doi: 10.1002/1097-0142(195607/08)9:4<792::aid-cncr2820090429>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  7. Jones S. E., Butler J. J., Byrne G. E., Jr, Coltman C. A., Jr, Moon T. E. Histopathologic review of lymphoma cases from the Southwest Oncology Group. Cancer. 1977 Mar;39(3):1071–1076. doi: 10.1002/1097-0142(197703)39:3<1071::aid-cncr2820390310>3.0.co;2-c. [DOI] [PubMed] [Google Scholar]
  8. Jones S. E., Fuks Z., Bull M., Kadin M. E., Dorfman R. F., Kaplan H. S., Rosenberg S. A., Kim H. Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases. Cancer. 1973 Apr;31(4):806–823. doi: 10.1002/1097-0142(197304)31:4<806::aid-cncr2820310408>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  9. Levine G. D., Dorfman R. F. Nodular lymphoma: an ultrastructural study of its relationship to germinal centers and a correlation of light and electron microscopic findings. Cancer. 1975 Jan;35(1):148–164. doi: 10.1002/1097-0142(197501)35:1<148::aid-cncr2820350121>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  10. Lotz M. J., Chabner B., DeVita V. T., Jr, Johnson R. E., Berard C. W. Pathological staging of 100 consecutive untreated patients with non-Hodgkin's lymphomas: extramedullary sites of disease. Cancer. 1976 Jan;37(1):266–270. doi: 10.1002/1097-0142(197601)37:1<266::aid-cncr2820370136>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  11. Lukes R. J., Butler J. J. The pathology and nomenclature of Hodgkin's disease. Cancer Res. 1966 Jun;26(6):1063–1083. [PubMed] [Google Scholar]
  12. Patchefsky A. S., Brodovsky H. S., Menduke H., Southard M., Brooks J., Nicklas D., Hoch W. S. Non-Hodgkin's lymphomas: a clinicopathologic study of 293 cases. Cancer. 1974 Oct;34(4):1173–1186. doi: 10.1002/1097-0142(197410)34:4<1173::aid-cncr2820340429>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  13. Qazi R., Aisenberg A. C., Long J. C. The natural history of nodular lymphoma. Cancer. 1976 Apr;37(4):1923–1927. doi: 10.1002/1097-0142(197604)37:4<1923::aid-cncr2820370443>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  14. Warnke R. A., Kim H., Fuks Z., Dorfman R. F. The coexistence of nodular and diffuse patterns in nodular non-Hodgkin's lymphomas: significance and clinicopathologic correlation. Cancer. 1977 Sep;40(3):1229–1233. doi: 10.1002/1097-0142(197709)40:3<1229::aid-cncr2820400337>3.0.co;2-f. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES